Profile: UCB Inc. is a global biopharma company involved in research, development & distribution of pharmaceutical & biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune & inflammatory disorders and oncology. Our Xyzal® is an antihistamine for the symptomatic treatment of allergic rhinitis, including persistent allergic rhinitis, and chronic idiopathic urticaria. Our Keppra® is indicated for the treatment of several types of epilepsy including add-on treatment for adults and children from 4 years of age with partial onset seizures.